Skip to main content

Quanterix Simoa Neurology 4-Plex A Assay

Quanterix launched the Simoa Neurology 4-Plex A assay, which the firm said is the first test that can simultaneously measure four protein biomarkers from either CFS or directly from blood samples, for studying traumatic brain injury and other neurodegenerative disorders. The four biomarkers on the panel include neurofilament light, tau, glial fibrillary acidic protein, and ubiquitin carboxyl-terminal hydrolase L1.